Skip to main content
Erschienen in: Digestive Diseases and Sciences 10/2007

01.10.2007 | Original Article

Gene Expression Profile Analysis of the Spontaneous Reversal of Rat Hepatic Fibrosis by cDNA Microarray

verfasst von: Qin Pan, Zhong-Bing Zhang, Xin Zhang, Jian Shi, Yue-Xiang Chen, Ze-Guang Han, Wei-Fen Xie

Erschienen in: Digestive Diseases and Sciences | Ausgabe 10/2007

Einloggen, um Zugang zu erhalten

Abstract

Our aim was to gain insight into the gene expression profile during hepatic fibrosis autoreversal. Spontaneous recovery from hepatic fibrosis was created in SD rats by CCl4 exposure for 8 weeks and then withdrawal for 6 weeks. Then differentially expressed genes during regression of fibrosis were analyzed using cDNA microarray. Results obtained were further subjected to hierarchical clustering and validated by semiquantitative RT-PCR. Expression of Mapk1 and Rps6ka1, which are critical members of the mitogen-activated protein kinase (MAPK) signaling pathway, was also investigated by Northern blot and immunohistochemistry. Microarray hybridization identified 254 genes differentially expressed throughout resolution of fibrosis. Being verified by RT-PCR, up- or down-regulated genes were classified into various groups according to clustering and function: (1) metabolic enzymes, (2) facilitated diffusion proteins/transporters/symporters, (3) gastrointestinal hormones/receptors, (4) lipoproteins/fatty acid binding proteins, (5) transcription factors/nuclear factors, and (6) the MAPK signaling pathway. The mRNA level of Mapk1 increased greatly as hepatic fibrosis reversed. Meanwhile Mapk1 and Rps6ka1 were proven to be expressed in hepatocytes and absent from mesenchymal cells. Six groups of genes exhibit a close relation to the recovery of CCl4-induced hepatic fibrosis. The MAPK signaling-dependent pathway, representing one of the gene groups, may contribute to the reversal of hepatic fibrosis.
Literatur
1.
Zurück zum Zitat Iredale JP, Benyon RC, Pickering J, et al. (1998) Mechanisms of spontaneous resolution of rat liver fibrosis: hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibition. J Clin Invest 102:538–549PubMedCrossRef Iredale JP, Benyon RC, Pickering J, et al. (1998) Mechanisms of spontaneous resolution of rat liver fibrosis: hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibition. J Clin Invest 102:538–549PubMedCrossRef
2.
Zurück zum Zitat Hammel P, Couvelard A, O’Toole D, et al. (2001) Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med 344:418–423PubMedCrossRef Hammel P, Couvelard A, O’Toole D, et al. (2001) Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med 344:418–423PubMedCrossRef
3.
Zurück zum Zitat Dienstag JL, Goldin RD, Heathcote EJ, et al. (2003) Histological outcome during long-term lamivudine therapy. Gastroenterology 124:105–117PubMedCrossRef Dienstag JL, Goldin RD, Heathcote EJ, et al. (2003) Histological outcome during long-term lamivudine therapy. Gastroenterology 124:105–117PubMedCrossRef
4.
Zurück zum Zitat Yoshiji H, Kuriyama S, Yoshii J, et al. (2002) Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse. Hepatology 36:850–860PubMed Yoshiji H, Kuriyama S, Yoshii J, et al. (2002) Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse. Hepatology 36:850–860PubMed
5.
Zurück zum Zitat Ueki T, Kaneda Y, Tsutsui H, et al. (1999) Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 5:226–230PubMedCrossRef Ueki T, Kaneda Y, Tsutsui H, et al. (1999) Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 5:226–230PubMedCrossRef
6.
Zurück zum Zitat Salgado S, Garcia J, Vera J, et al. (2000) Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy. Mol Ther 2:545–551PubMedCrossRef Salgado S, Garcia J, Vera J, et al. (2000) Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy. Mol Ther 2:545–551PubMedCrossRef
7.
Zurück zum Zitat Abdollahi A, Gruver BN, Patriotis C, Hamilton TC (2003) Identification of epidermal growth factor-responsive genes in normal rat ovarian surface epithelial cells. Biochem Biophys Res Commun 307:188–197PubMedCrossRef Abdollahi A, Gruver BN, Patriotis C, Hamilton TC (2003) Identification of epidermal growth factor-responsive genes in normal rat ovarian surface epithelial cells. Biochem Biophys Res Commun 307:188–197PubMedCrossRef
8.
Zurück zum Zitat Pan Q, Li DG, Lu HM, Lu LY, You HN, Xu QF (2004) Relationship between somatostatin receptors and activation of hepatic stellate cell. Chin Med J 117:1665–1669PubMed Pan Q, Li DG, Lu HM, Lu LY, You HN, Xu QF (2004) Relationship between somatostatin receptors and activation of hepatic stellate cell. Chin Med J 117:1665–1669PubMed
9.
Zurück zum Zitat Zender L, Hütker S, Liedtke C, et al. (2003) Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc Natl Acad Sci USA 100:7797–7802PubMedCrossRef Zender L, Hütker S, Liedtke C, et al. (2003) Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc Natl Acad Sci USA 100:7797–7802PubMedCrossRef
10.
Zurück zum Zitat Wang Y, Wang F, Sun T, et al. (2004) Entire mitogen activated protein kinase (MAPK) pathway is present in preimplantation mouse embryos. Dev Dyn 231:72–87PubMedCrossRef Wang Y, Wang F, Sun T, et al. (2004) Entire mitogen activated protein kinase (MAPK) pathway is present in preimplantation mouse embryos. Dev Dyn 231:72–87PubMedCrossRef
11.
Zurück zum Zitat Gilot D, Loyer P, Corlu A, et al. (2002) Liver protection from apoptosis requires both blockage of initiator caspase activities and inhibition of ASK1/JNK pathway via glutathione S-transferase regulation. J Biol Chem 277:49220–49229PubMedCrossRef Gilot D, Loyer P, Corlu A, et al. (2002) Liver protection from apoptosis requires both blockage of initiator caspase activities and inhibition of ASK1/JNK pathway via glutathione S-transferase regulation. J Biol Chem 277:49220–49229PubMedCrossRef
12.
Zurück zum Zitat Sharma R, Yang Y, Sharma A, Awasthi S, Awasthi YC (2004) Antioxidant role of glutathione S-transferases: protection against oxidant toxicity and regulation of stress-mediated apoptosis. Antioxid Redox Signal 6:289–300PubMedCrossRef Sharma R, Yang Y, Sharma A, Awasthi S, Awasthi YC (2004) Antioxidant role of glutathione S-transferases: protection against oxidant toxicity and regulation of stress-mediated apoptosis. Antioxid Redox Signal 6:289–300PubMedCrossRef
13.
Zurück zum Zitat Jones BE, Liu H, Lo CR, Koop DR, Czaja MJ (2002) Cytochrome P450 2E1 expression induces hepatocyte resistance to cell death from oxidative stress. Antioxid Redox Signal 4:701–709PubMedCrossRef Jones BE, Liu H, Lo CR, Koop DR, Czaja MJ (2002) Cytochrome P450 2E1 expression induces hepatocyte resistance to cell death from oxidative stress. Antioxid Redox Signal 4:701–709PubMedCrossRef
14.
Zurück zum Zitat Di Giovanni S, Mirabella M, Papacci M, Odoardi F, Silvestri G, Servidei S (2001) Apoptosis and ROS detoxification enzymes correlate with cytochrome c oxidase deficiency in mitochondrial encephalomyopathies. Mol Cell Neurosci 17:696–705PubMedCrossRef Di Giovanni S, Mirabella M, Papacci M, Odoardi F, Silvestri G, Servidei S (2001) Apoptosis and ROS detoxification enzymes correlate with cytochrome c oxidase deficiency in mitochondrial encephalomyopathies. Mol Cell Neurosci 17:696–705PubMedCrossRef
15.
Zurück zum Zitat Bastien MC, Leblond F, Pichette V, Villeneuve JP (2000) Differential alteration of cytochrome P450 isoenzymes in two experimental models of cirrhosis. Can J Physiol Pharmacol 78:912–919PubMedCrossRef Bastien MC, Leblond F, Pichette V, Villeneuve JP (2000) Differential alteration of cytochrome P450 isoenzymes in two experimental models of cirrhosis. Can J Physiol Pharmacol 78:912–919PubMedCrossRef
16.
Zurück zum Zitat Tsuneyama K, Harada K, Kono N, et al. (2002) Damaged interlobular bile ducts in primary biliary cirrhosis show reduced expression of glutathione-S-transferase-pi and aberrant expression of 4-hydroxynonenal. J Hepatol 37:176–183PubMedCrossRef Tsuneyama K, Harada K, Kono N, et al. (2002) Damaged interlobular bile ducts in primary biliary cirrhosis show reduced expression of glutathione-S-transferase-pi and aberrant expression of 4-hydroxynonenal. J Hepatol 37:176–183PubMedCrossRef
17.
Zurück zum Zitat Gruebele A, Zawaski K, Kaplan D, Novak RF (1996) Cytochrome P4502E1- and cytochrome P4502B1/2B2-catalyzed carbon tetrachloride metabolism: effects on signal transduction as demonstrated by altered immediate-early (c-Fos and c-Jun) gene expression and nuclear AP-1 and NF-kappa B transcription factor levels. Drug Metab Dispos 24:15–22PubMed Gruebele A, Zawaski K, Kaplan D, Novak RF (1996) Cytochrome P4502E1- and cytochrome P4502B1/2B2-catalyzed carbon tetrachloride metabolism: effects on signal transduction as demonstrated by altered immediate-early (c-Fos and c-Jun) gene expression and nuclear AP-1 and NF-kappa B transcription factor levels. Drug Metab Dispos 24:15–22PubMed
18.
Zurück zum Zitat Hung DY, Siebert GA, Chang P, Burczynski FJ, Roberts MS (2005) Reduced hepatic extraction of palmitate in steatosis correlated to lower level of liver fatty acid binding protein. Am. J. Physiol. Gastrointest Liver Physiol 288:G93–G100PubMedCrossRef Hung DY, Siebert GA, Chang P, Burczynski FJ, Roberts MS (2005) Reduced hepatic extraction of palmitate in steatosis correlated to lower level of liver fatty acid binding protein. Am. J. Physiol. Gastrointest Liver Physiol 288:G93–G100PubMedCrossRef
19.
Zurück zum Zitat Koruk M, Savas MC, Yilmaz O, et al. (2003) Serum lipids, lipoproteins and apolipoprotein levels in patients with nonalcoholic steatohepatitis. J Clin Gastroenterol 37:177–182PubMedCrossRef Koruk M, Savas MC, Yilmaz O, et al. (2003) Serum lipids, lipoproteins and apolipoprotein levels in patients with nonalcoholic steatohepatitis. J Clin Gastroenterol 37:177–182PubMedCrossRef
20.
Zurück zum Zitat Hsu JC, Bravo R, Taub R (1992) Interactions among LRF-1, JunB, c-Jun, and c-Fos define a regulatory program in the G1 phase of liver regeneration. Mol Cell Biol 12:4654–4665PubMed Hsu JC, Bravo R, Taub R (1992) Interactions among LRF-1, JunB, c-Jun, and c-Fos define a regulatory program in the G1 phase of liver regeneration. Mol Cell Biol 12:4654–4665PubMed
21.
Zurück zum Zitat Rahmani M, Peron P, Weitzman J, Bakiri L, Lardeux B, Bernuau D (2001) Functional cooperation between JunD and NF-kappaB in rat hepatocytes. Oncogene 20:5132–5142PubMedCrossRef Rahmani M, Peron P, Weitzman J, Bakiri L, Lardeux B, Bernuau D (2001) Functional cooperation between JunD and NF-kappaB in rat hepatocytes. Oncogene 20:5132–5142PubMedCrossRef
22.
Zurück zum Zitat Fabregat I, de Juan C, Nakamura T, Benito M (1992) Growth stimulation of rat fetal hepatocytes in response to hepatocyte growth factor:modulation of c-myc and c-fos expression. Biochem Biophys Res Commun 189:684–690PubMedCrossRef Fabregat I, de Juan C, Nakamura T, Benito M (1992) Growth stimulation of rat fetal hepatocytes in response to hepatocyte growth factor:modulation of c-myc and c-fos expression. Biochem Biophys Res Commun 189:684–690PubMedCrossRef
23.
Zurück zum Zitat Roberts RA, James NH, Cosulich SC (2000) The role of protein kinase B and mitogen-activated protein kinase in epidermal growth factor and tumor necrosis factor alpha-mediated rat hepatocyte survival and apoptosis. Hepatology 31:420–427PubMedCrossRef Roberts RA, James NH, Cosulich SC (2000) The role of protein kinase B and mitogen-activated protein kinase in epidermal growth factor and tumor necrosis factor alpha-mediated rat hepatocyte survival and apoptosis. Hepatology 31:420–427PubMedCrossRef
24.
Zurück zum Zitat Adachi T, Nakashima S, Saji S, Nakamura T, Nozawa Y (1995) Roles of prostaglandin production and mitogen-activated protein kinase activation in hepatocyte growth factor-mediated rat hepatocyte proliferation. Hepatology 21:1668–1174PubMed Adachi T, Nakashima S, Saji S, Nakamura T, Nozawa Y (1995) Roles of prostaglandin production and mitogen-activated protein kinase activation in hepatocyte growth factor-mediated rat hepatocyte proliferation. Hepatology 21:1668–1174PubMed
25.
Zurück zum Zitat Sugiura T, Imai E, Moriyama T, Horio M, Hori M (2000) Calcium channel blockers inhibit proliferation and matrix production in rat mesangial cells: possible mechanism of suppression of AP-1 and CREB activities. Nephron 85:71–80PubMedCrossRef Sugiura T, Imai E, Moriyama T, Horio M, Hori M (2000) Calcium channel blockers inhibit proliferation and matrix production in rat mesangial cells: possible mechanism of suppression of AP-1 and CREB activities. Nephron 85:71–80PubMedCrossRef
26.
Zurück zum Zitat Wei L, Xiao AY, Jin C, Yang A, Lu ZY, Yu SP (2004) Effects of chloride and potassium channel blockers on apoptotic cell shrinkage and apoptosis in cortical neurons. Pflugers Arch 448:325–334PubMedCrossRef Wei L, Xiao AY, Jin C, Yang A, Lu ZY, Yu SP (2004) Effects of chloride and potassium channel blockers on apoptotic cell shrinkage and apoptosis in cortical neurons. Pflugers Arch 448:325–334PubMedCrossRef
27.
Zurück zum Zitat Lee AL, Dumas TC, Tarapore PE, et al. (2003) Potassium channel gene therapy can prevent neuron death resulting from necrotic and apoptotic insults. J Neurochem 86:1079–1088PubMedCrossRef Lee AL, Dumas TC, Tarapore PE, et al. (2003) Potassium channel gene therapy can prevent neuron death resulting from necrotic and apoptotic insults. J Neurochem 86:1079–1088PubMedCrossRef
28.
Zurück zum Zitat Suh KS, Mutoh M, Gerdes M, et al. (2005) Antisense suppression of the chloride intracellular channel family induces apoptosis, enhances tumor necrosis factor α-induced apoptosis, and inhibits tumor growth. Cancer Res 65:562–571PubMed Suh KS, Mutoh M, Gerdes M, et al. (2005) Antisense suppression of the chloride intracellular channel family induces apoptosis, enhances tumor necrosis factor α-induced apoptosis, and inhibits tumor growth. Cancer Res 65:562–571PubMed
29.
Zurück zum Zitat Wang GL, Wang XR, Lin MJ, He H, Lan XJ, Guan YY (2002) Deficiency in ClC-3 chloride channels prevents rat aortic smooth muscle cell proliferation. Circ Res 91:E28–E32PubMedCrossRef Wang GL, Wang XR, Lin MJ, He H, Lan XJ, Guan YY (2002) Deficiency in ClC-3 chloride channels prevents rat aortic smooth muscle cell proliferation. Circ Res 91:E28–E32PubMedCrossRef
30.
Zurück zum Zitat Van Coppenolle F, Skryma R, Ouadid-Ahidouch H, et al. (2004) Prolactin stimulates cell proliferation through a long form of prolactin receptor and K+ channel activation. Biochem J 377:569–578PubMed Van Coppenolle F, Skryma R, Ouadid-Ahidouch H, et al. (2004) Prolactin stimulates cell proliferation through a long form of prolactin receptor and K+ channel activation. Biochem J 377:569–578PubMed
31.
Zurück zum Zitat Barros LF, Stutzin A, Calixto A, et al. (2001) Nonselective cation channels as effectors of free radical-induced rat liver cell necrosis. Hepatology 33:114–122PubMedCrossRef Barros LF, Stutzin A, Calixto A, et al. (2001) Nonselective cation channels as effectors of free radical-induced rat liver cell necrosis. Hepatology 33:114–122PubMedCrossRef
32.
Zurück zum Zitat Splinter PL, Masyuk AI, Marinelli RA, LaRusso NF (2004) AQP4 transfected into mouse cholangiocytes promotes water transport in biliary epithelia. Hepatology 39:109–116PubMedCrossRef Splinter PL, Masyuk AI, Marinelli RA, LaRusso NF (2004) AQP4 transfected into mouse cholangiocytes promotes water transport in biliary epithelia. Hepatology 39:109–116PubMedCrossRef
33.
Zurück zum Zitat Noveral JP, Grunstein MM (1995) Tachykinin regulation of airway smooth muscle cell proliferation. Am J Physiol 269:L339–L343PubMed Noveral JP, Grunstein MM (1995) Tachykinin regulation of airway smooth muscle cell proliferation. Am J Physiol 269:L339–L343PubMed
34.
Zurück zum Zitat Taniguchi F, Harada T, Sakamoto Y, et al. (2003) Activation of mitogen-activated protein kinase pathway by keratinocyte growth factor or fibroblast growth factor-10 promotes cell proliferation in human endometrial carcinoma cells. J Clin Endocrinol Metab 88:773–780PubMedCrossRef Taniguchi F, Harada T, Sakamoto Y, et al. (2003) Activation of mitogen-activated protein kinase pathway by keratinocyte growth factor or fibroblast growth factor-10 promotes cell proliferation in human endometrial carcinoma cells. J Clin Endocrinol Metab 88:773–780PubMedCrossRef
35.
Zurück zum Zitat Welsh DJ, Harnett M, MacLean M, Peacock AJ (2004) Proliferation and signaling in fibroblasts: role of 5-hydroxytryptamine2A receptor and transporter. Am J Respir Crit Care Med 170:252–259PubMedCrossRef Welsh DJ, Harnett M, MacLean M, Peacock AJ (2004) Proliferation and signaling in fibroblasts: role of 5-hydroxytryptamine2A receptor and transporter. Am J Respir Crit Care Med 170:252–259PubMedCrossRef
36.
Zurück zum Zitat Geraldes P, Sirois MG, Tanguay JF (2003) Specific contribution of estrogen receptors on mitogen-activated protein kinase pathways and vascular cell activation. Circ Res 93:399–405PubMedCrossRef Geraldes P, Sirois MG, Tanguay JF (2003) Specific contribution of estrogen receptors on mitogen-activated protein kinase pathways and vascular cell activation. Circ Res 93:399–405PubMedCrossRef
37.
Zurück zum Zitat Inoue H, Shimizu I, Lu G, et al. (2003) Idoxifene and estradiol enhance antiapoptotic activity through estrogen receptor-beta in cultured rat hepatocytes. Dig Dis Sci 48:570–580PubMedCrossRef Inoue H, Shimizu I, Lu G, et al. (2003) Idoxifene and estradiol enhance antiapoptotic activity through estrogen receptor-beta in cultured rat hepatocytes. Dig Dis Sci 48:570–580PubMedCrossRef
38.
Zurück zum Zitat Upadhyay D, Bundesmann M, Panduri V, Correa-Meyer E, Kamp DW (2004) Fibroblast growth factor-10 attenuates H2O2-induced alveolar epithelial cell DNA damage: role of MAPK activation and DNA repair. Am J Respir Cell Mol Biol 31:107–113PubMedCrossRef Upadhyay D, Bundesmann M, Panduri V, Correa-Meyer E, Kamp DW (2004) Fibroblast growth factor-10 attenuates H2O2-induced alveolar epithelial cell DNA damage: role of MAPK activation and DNA repair. Am J Respir Cell Mol Biol 31:107–113PubMedCrossRef
39.
Zurück zum Zitat Chao TC, Chao HH, Lin JD, Chen MF (1999) Somatostatin and octreotide modulate the function of Kupffer cells in liver cirrhosis. Regul Pept 79:117–124PubMedCrossRef Chao TC, Chao HH, Lin JD, Chen MF (1999) Somatostatin and octreotide modulate the function of Kupffer cells in liver cirrhosis. Regul Pept 79:117–124PubMedCrossRef
40.
Zurück zum Zitat Yuyama K, Yamamoto H, Nishizaki I, Kato T, Sora I, Yamamoto T (2003) Caspase-independent cell death by low concentrations of nitric oxide in PC12 cells: involvement of cytochrome C oxidase inhibition and the production of reactive oxygen species in mitochondria. J Neurosci Res 73:351–363PubMedCrossRef Yuyama K, Yamamoto H, Nishizaki I, Kato T, Sora I, Yamamoto T (2003) Caspase-independent cell death by low concentrations of nitric oxide in PC12 cells: involvement of cytochrome C oxidase inhibition and the production of reactive oxygen species in mitochondria. J Neurosci Res 73:351–363PubMedCrossRef
41.
Zurück zum Zitat Smith JA, Poteet-Smith CE, Malarkey K, Sturgill TW (1999) Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo. J Biol Chem 274:2893–2898PubMedCrossRef Smith JA, Poteet-Smith CE, Malarkey K, Sturgill TW (1999) Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo. J Biol Chem 274:2893–2898PubMedCrossRef
42.
Zurück zum Zitat Gao R, Ball DK, Perbal B, Brigstock DR (2004) Connective tissue growth factor induces c-fos gene activation and cell proliferation through p44/42 MAP kinase in primary rat hepatic stellate cells. J Hepatol 40:431–438PubMedCrossRef Gao R, Ball DK, Perbal B, Brigstock DR (2004) Connective tissue growth factor induces c-fos gene activation and cell proliferation through p44/42 MAP kinase in primary rat hepatic stellate cells. J Hepatol 40:431–438PubMedCrossRef
43.
Zurück zum Zitat Reif S, Aeed H, Shilo Y, et al. (2004) Treatment of thioacetamide-induced liver cirrhosis by the Ras antagonist, farnesylthiosalicylic acid. J Hepatol 41:235–241PubMedCrossRef Reif S, Aeed H, Shilo Y, et al. (2004) Treatment of thioacetamide-induced liver cirrhosis by the Ras antagonist, farnesylthiosalicylic acid. J Hepatol 41:235–241PubMedCrossRef
Metadaten
Titel
Gene Expression Profile Analysis of the Spontaneous Reversal of Rat Hepatic Fibrosis by cDNA Microarray
verfasst von
Qin Pan
Zhong-Bing Zhang
Xin Zhang
Jian Shi
Yue-Xiang Chen
Ze-Guang Han
Wei-Fen Xie
Publikationsdatum
01.10.2007
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 10/2007
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9676-1

Weitere Artikel der Ausgabe 10/2007

Digestive Diseases and Sciences 10/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.